Direct comparison of regulators of calcification between bone and vessels in humans.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Bone

• Publication date

  2016-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bone.2016.04.016PMID 27108945
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vascular calcification is coupled with phenotypic conversion of vascular smooth muscle cells through Klf5-mediated transactivation of the Runx2 promoter

  2014influential reference
• Osteoprotegerin Inhibits Calcification of Vascular Smooth Muscle Cell via Down Regulation of the Notch1-RBP-Jκ/Msx2 Signaling Pathway

  2013cited by this paper
• Platelets express and release osteocalcin and co‐localize in human calcified atherosclerotic plaques

  2013cited by this paper
• Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization.

  2013cited by this paper
• Functional interaction of osteogenic transcription factors Runx2 and Vdr in transcriptional regulation of Opn during soft tissue calcification.

  2013cited by this paper
• Runx2/Smad3 complex negatively regulates TGF-β-induced connective tissue growth factor gene expression in vascular smooth muscle cells.

  2012cited by this paper
• Osteocalcin positive CD133+/CD34-/KDR+ progenitor cells as an independent marker for unstable atherosclerosis.

  2012cited by this paper
• Aortic Calcification and Bone Metabolism: The Relationship between Aortic Calcification, BMD, Vertebral Fracture, 25-Hydroxyvitamin D, and Osteocalcin

  2012cited by this paper
• Runx2/Smad3 complex negatively regulates TGF-β-induced connective tissue growth factor gene expression in vascular smooth muscle cells

  2011cited by this paper
• Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and Phosphate

  2011influential reference
• Preferential Activation of SMAD1/5/8 on the Fibrosa Endothelium in Calcified Human Aortic Valves - Association with Low BMP Antagonists and SMAD6

  2011cited by this paper
• Fibroblast growth factor-2 induces osteogenic differentiation through a Runx2 activation in vascular smooth muscle cells.

  2010cited by this paper
• Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species

  2010cited by this paper
• Osteoprotegerin, vascular calcification and atherosclerosis.

  2009cited by this paper
• Arteriosclerosis: rethinking the current classification.

  2009influential reference
• OPG/RANK/RANKL signaling system and its significance in nephrology.

  2009influential reference
• Vascular calcifications as a marker of increased cardiovascular risk: A meta-analysis

  2009cited by this paper
• Vascular calcification and bone disease: the calcification paradox.

  2009influential reference
• Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis

  2008cited by this paper
• Selective Inhibitory Effects of Smad6 on Bone Morphogenetic Protein Type I Receptors*

  2007cited by this paper
• Bone health and vascular calcification relationships in chronic kidney disease

  2007cited by this paper
• Biology of RANK, RANKL, and osteoprotegerin

  2007cited by this paper
• Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro.

  2007cited by this paper
• Vascular calcification and osteoporosis—from clinical observation towards molecular understanding

  2007cited by this paper
• Bone morphogenetic proteins regulate osteoprotegerin and its ligands in human vascular smooth muscle cells

  2007influential reference
• Molecular determinants of vascular calcification: a bench to bedside view.

  2006cited by this paper
• Site-Specific In Vivo Calcification and Osteogenesis Stimulated by Bone Sialoprotein

  2006cited by this paper
• Molecular mechanisms of vascular calcification: lessons learned from the aorta.

  2006cited by this paper
• The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease

  2006cited by this paper
• Novel Conformation-Specific Antibodies Against Matrix γ-Carboxyglutamic Acid (Gla) Protein: Undercarboxylated Matrix Gla Protein as Marker for Vascular Calcification

  2005cited by this paper
• Regulation of Vascular Calcification Roles of Phosphate and Osteopontin

  2005cited by this paper
• Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases.

  2004cited by this paper
• Aortic calcification and the risk of osteoporosis and fractures.

  2004cited by this paper
• Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis.

  2004cited by this paper
• Molecular, endocrine, and genetic mechanisms of arterial calcification.

  2004cited by this paper
• Expression of matrix Gla protein and osteonectin mRNA by human aortic smooth muscle cells.

  2004cited by this paper
• Biochemical Characterization of the Serum Fetuin-Mineral Complex*

  2003cited by this paper
• The Role of RANKL (TRANCE/TNFSF11), a Tumor Necrosis Factor Family Member, in Skeletal Development: Effects of Gene Knockout and Transgenic Rescue

  2003cited by this paper
• Osteo/Chondrocytic Transcription Factors and Their Target Genes Exhibit Distinct Patterns of Expression in Human Arterial Calcification

  2003influential reference
• Mechanisms balancing skeletal matrix synthesis and degradation.

  2002cited by this paper
• Osteopontin--a molecule for all seasons.

  2002cited by this paper
• Inactivation of the Osteopontin Gene Enhances Vascular Calcification of Matrix Gla Protein–deficient Mice

  2002cited by this paper
• Vascular calcification: expression patterns of the osteoblast-specific gene core binding factor alpha-1 and the protective factor matrix gla protein in human atherogenesis.

  2001cited by this paper
• Arterial calcification: A review of mechanisms, animal models, and the prospects for therapy

  2001cited by this paper
• Differential Expression of Bone Matrix Regulatory Proteins in Human Atherosclerotic Plaques

  2001cited by this paper
• Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure.

  2001cited by this paper
• Bone loss and the progression of abdominal aortic calcification over a 25 year period: The Framingham heart study

  2001cited by this paper
• Osteoprotegerin

  2001cited by this paper
• A role for Smad6 in development and homeostasis of the cardiovascular system

  2000cited by this paper
• Expression of mineralisation-regulating proteins in association with human vascular calcification

  2000cited by this paper
• Osteoprotegerin Reverses Osteoporosis by Inhibiting Endosteal Osteoclasts and Prevents Vascular Calcification by Blocking a Process Resembling Osteoclastogenesis

  2000cited by this paper
• Bone sialoprotein mediates human endothelial cell attachment and migration and promotes angiogenesis.

  2000cited by this paper
• Matrix Gla Protein Synthesis and Gamma-carboxylation in the Aortic Vessel Wall and Proliferating Vascular Smooth Muscle Cells

  1999cited by this paper
• Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome

  1999cited by this paper
• The expression of cartilage oligomeric matrix protein, thrombospondin-1, bone sialoprotein and osteopontin in calcified and non-calcified arterial lesions.

  1998cited by this paper
• osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.

  1998cited by this paper
• Matrix proteins associated with bone calcification are present in human vascular smooth muscle cells grownin vitro

  1995cited by this paper
• Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation.

  1994cited by this paper
• High expression of genes for calcification-regulating proteins in human atherosclerotic plaques.

  1994cited by this paper
• Molecular cloning and physical mapping of the genome of Bombyx mori nuclear polyhedrosis virus.

  1990influential reference
• Osteocalcin: isolation, characterization, and detection.

  1984cited by this paper
• Inactivation of the Osteopontin Gene Enhances Vascular Calcification of Matrix Gla Protein–deficient Mice: Evidence for Osteopontin as an Inducible Inhibitor of Vascular Calcification In Vivo

  year unknowncited by this paper

• Stiffness-sensitive gene regulation in human mesenchymal stem cells: modelling mechanotransduction to predict mineralization and bone protein expression.

  2025cites this paper
• Tumor Necrosis Factor Family Members and Myocardial Ischemia-Reperfusion Injury: State of the Art and Therapeutic Implications

  2023cites this paper
• Theoretical Evidence of Osteoblast Self-Inhibition after Activation of the Genetic Regulatory Network Controlling Mineralization.

  2022cites this paper
• Transcriptional atlas analysis from multiple tissues reveals the expression specificity patterns in beef cattle

  2022cites this paper
• Correlation between serum Dickkopf-1 (DKK1) levels and coronary artery stenosis.

  2022cites this paper
• The Emerging Role of Bone Markers in Diagnosis and Risk Stratification of Patients With Coronary Artery Disease

  2019cites this paper
• Osseous Remodeling Around Dental Implants.

  2019cites this paper
• The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases

  2017cites this paper
• Microcalcifications in stone-obstructed human submandibular gland are associated with apoptosis and cell proliferation.

  2017cites this paper